About this trial
PURPOSE
The two related purposes of the RE-TyPE study are:
1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital
HYPOTHESES
1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital
Eligibility criteria
Qualifiers
Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital
Written informed consent
Disqualifiers
Low risk, intermediate-low risk or high risk PE*
>48 hours since arrival to hospital
Expected inability to comply with the protocol (e.g. dementia)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Sahlgrenska University Hospital
Lead sponsor
Gothia Forum - Center for Clinical Trial
Collaborator